Metraipolis › archive › dc_24da0dea9da8

Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy — Europe PMC PMID:42151532

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42151532
DOI
10.1038/s41598-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-01T15:26:19.656Z
SHA-256 of the archived text
0102a5e6c79cc0630f60cf6f36e6240b06741f4493ee6f452bb3118e19f59cbe
Stable URL of this page
https://metraipolis.com/documento/dc_24da0dea9da8

How to cite

Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy — Europe PMC PMID:42151532 — Europe PMC (en), https://europepmc.org/article/MED/42151532 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_24da0dea9da8 (Metraipolis archive dc_24da0dea9da8, sha256 0102a5e6c79cc0630f60cf6f36e6240b06741f4493ee6f452bb3118e19f59cbe)
BibTeX
@misc{dc24da0dea9da8,
  title = {Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy — Europe PMC PMID:42151532},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42151532},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_24da0dea9da8; sha256 0102a5e6c79cc0630f60cf6f36e6240b06741f4493ee6f452bb3118e19f59cbe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151532. Agents can read the archived copy with the MCP tool read_document.